Condition
Non-Hodgkin Lymphoma, B-cell clinical trials and research
As of November 12, 2026, Find a Trial lists 4 Non-Hodgkin Lymphoma, B-cell clinical trials that are recruiting, at sites in 6 countries (most in China (2), France (1), Poland (1)). By phase: Phase 2 (1), Early Phase 1 (1), Phase 1/2 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 4Clinical trials
- 6Countries
Newest Non-Hodgkin Lymphoma, B-cell clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| Treatment for relapsed or refractory aggressive B-cell non-Hodgkin lymphoma | Phase 2 | Le Mans and 34 other locations | Recruiting | Aug 2, 2024 |
| Dose-escalation of CD19/CD22/BCMA CAR‑T for relapsed or refractory B‑cell non‑Hodgkin lymphoma | Early Phase 1 | Shanghai, Shanghai Municipality | Recruiting | Jun 6, 2024 |
| CAR T Cell Therapy for Resistant B-cell Cancers | Phase 1/2 | Beijing, Beijing Municipality | Recruiting | Jan 19, 2024 |
| Evaluating the impact of new monoclonal antibodies in treating B-cell Non-Hodgkin Lymphoma in Italy | — | Viagrande, Catania and 60 other locations | Recruiting | Aug 23, 2023 |
All recruiting trials (4)
-
Treatment for relapsed or refractory aggressive B-cell non-Hodgkin lymphoma
This study is testing a new treatment called MEN1703, alone and with another drug, to see if it helps people with aggressive B-cell non-Hodgkin lymphoma who haven't responded to other treatments.
-
Dose-escalation of CD19/CD22/BCMA CAR‑T for relapsed or refractory B‑cell non‑Hodgkin lymphoma
This trial will try a CAR‑T therapy that targets CD19, CD22, and BCMA in people with relapsed or refractory B‑cell non‑Hodgkin lymphoma to find a safe dose.
-
CAR T Cell Therapy for Resistant B-cell Cancers
This study is testing a new CAR T cell therapy to see if it can safely help people with tough-to-treat B-cell cancers like leukemia and lymphoma.
-
Evaluating the impact of new monoclonal antibodies in treating B-cell Non-Hodgkin Lymphoma in Italy
This study is trying to see how well new monoclonal antibodies work for treating B-cell Non-Hodgkin Lymphoma patients in Italy and what side effects they might have.
Related topics
Quick answers
How many Non-Hodgkin Lymphoma, B-cell clinical trials are recruiting right now?
4, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 6 countries. The most sites are in China (2 trials), France (1 trial), Poland (1 trial), Spain (1 trial), United Kingdom (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2: 1, Early Phase 1: 1, Phase 1/2: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.